The White House Office of National Drug Control Policy yesterday released its national drug control strategy, intended to guide federal efforts to reduce the availability and use of illicit drugs and barriers to substance use disorder treatment. “While this strategy reflects the President’s top priority to address the current opioid crisis and reduce the number of Americans dying from these dangerous drugs, it also sets us on the path to develop further the capability, knowledge and infrastructure to respond to the evolving nature of the drug threat as we move deeper into the twenty-first century,” said James Carroll, director of national drug control policy. The strategy involves implementing a nationwide media campaign, building safe prescribing practices, expanding the use of prescription drug monitoring programs, enhancing research around evidence-based addiction treatment, eliminating barriers to treatment, combating illicit drug supply chains, and increasing the size of the addiction service workforce, among other initiatives.
 

Related News Articles

Headline
The Food and Drug Administration Friday approved the first generic naloxone nasal spray, an emergency treatment for opioid overdose intended for use in the…
Headline
April 27 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired prescription pills at sites…
Headline
The National Institutes of Health today selected several universities to partner with communities in Kentucky, Massachusetts, New York and Ohio to study the…
Headline
The Food and Drug Administration yesterday announced changes to the prescribing information included in outpatient opioid pain medication labels.
Headline
The Agency for Healthcare Research and Quality is accepting comments through April 25 on a draft report on treatment for acute pain.
Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…